In a session titled “Hemophilia Update: Our Cup Runneth Over,” presented at the 2021 annual meeting of the American Society of Hematology (ASH), experts in the treatment of bleeding disorders discussed the optimal use of factor concentrates in people with hemophilia, new and investigational alternatives to factor concentrates, and the promise of long-time control or even cure with gene therapy.
Alice Ma, MD, the Medical Alumni Loyalty Fund Distinguished Teaching Professor in the Division of Hematology was a featured expert in the conference update published by Medscape.
The article can be accessed here. A Medscape account is required to read the full article.